Last checked at 
AMSTERDAM, April 20 (Reuters) - The European Union's drug
regulator said on Tuesday there had been more than 300 cases
worldwide of rare blood clotting incidents combined with low
platelet counts after use of COVID-19 vaccines.
There were 287 occurrences with the AstraZeneca vaccine,
eight with Johnson & Johnson's shot, 25 for Pfizer and five for
Moderna, said Peter Arlett, Head of Data Analytics at the
European Medicines Agency (EMA).
(Reporting by Anthony Deutsch and Toby Sterling
Editing by Gareth JOnes)
